Contact Us
Drug Search Results
More Filters [+]

Faldaprevir

Alternative Names: faldaprevir, bi201335, bi 201335
Latest Update: 2023-09-30
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: HCV-NS3/4A Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Boehringer Ingelheim
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Faldaprevir

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Hepatitis C, Chronic|Hepatitis A|Liver Cirrhosis|HIV Infections|Hepatitis C|Acquired Immunodeficiency Syndrome

Phase 2: Hepatitis A|Hepatitis C, Chronic|Hepatitis C

Phase 1: Hepatitis A|Hepatitis C, Chronic|Kidney Diseases|Healthy Volunteers|Hepatitis C|HIV Infections|Liver Cirrhosis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
TRK-450-0203

P2

Completed

Hepatitis A|Hepatitis C, Chronic

2017-09-01

TRK-450-0201

P2

Completed

Hepatitis A|Hepatitis C, Chronic

2016-12-01

2012-003534-17

P2

Completed

Hepatitis C, Chronic

2016-06-08

NCT01608737

P3

Withdrawn

Hepatitis C, Chronic|Hepatitis A

2015-10-01

Recent News Events

Date

Type

Title

09/30/2023

PubMed

 Molecular Mechanisms of Resistance to Direct-Acting Antiviral (DAA) Drugs for the Treatment of Hepatitis C Virus Infections.

01/01/2012

PubMed

 Protease Inhibitors (HCV).

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions